Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients

Transplantation Proceedings

Volumn 33, Issue 3, 2001, Pages 2127-2128

  Braun, F ^a   Schutz E ^b   Peters, B ^a   Talaulicar, R ^a   Grupp, C ^c   Undre, N ^d   Schafer A ^d   Armstrong, V W ^c   Oellerich, M ^c   Ringe, B ^a,c  

^a Klinik Für Transplantationschirugie   (Germany)

^b Abteilung Klinische Chemie   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d Fujisawa GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD; CADAVER; CHRONIC KIDNEY FAILURE; DONOR; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; IMMUNOLOGY; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PHYSIOLOGY; TIME; TREATMENT OUTCOME;

ADULT; AGED; AREA UNDER CURVE; CADAVER; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; TACROLIMUS; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 18044401334     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(01)01970-4     Document Type: Article

References (6)

1. Ringe B, Braun F, Lorf T, et al: Transplant Proc 30:1415, 1998
2. Braun F, Lorf T, Schütz E, et al: Transplant Proc 28:3175, 1996
3. Braun F, Lorf T, Ringe B: Transplant Int 11:77, 1998
4. Braun F, Lorf T, Grupp C, et al: Transplant Proc 30:1221, 1998
5. Sattler M, Guengerich FP, Yun CH, et al: Drug Metab Dispos 20:753, 1992
6. Oellerich M, Armstrong VW, Schütz E, et al: Clin Biochem 31:309, 1998